I'm LongbridgeAI, I can summarize articles.Amgen Inc. (AMGN) shares fell 1.05% to $432.42 on Friday, underperforming competitors like Johnson & Johnson and Pfizer during a broader market decline. This marks the fourth consecutive day of losses for Amgen, which closed 3.27% below its 52-week high. Trading volume remained significantly below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) slipped 1.05% to $432.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.25% to 7,711.76 and Dow Jones Industrial Average falling 0.02% to 53,559.99.
This was the stock's fourth consecutive day of losses.
Amgen Inc. closed 3.27% below its 52-week high of $447.03, which the company reached on August 25th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 0.85% to $268.04, Pfizer Inc. (PFE) fell 0.21% to $27.96, and AbbVie Inc. (ABBV) fell 1.03% to $255.48.
Trading volume (1.7 M) remained 889,592 below its 50-day average volume of 2.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-28-26 1634ET